Tetsuhiro Chiba
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Hepatitis C virus research
- Cancer Research top 2%
Papers in
- Hepatology 84
- Hepatocellular Carcinoma Treatment and Prognosis 53
- Hepatitis C virus research 21
- Liver Disease and Transplantation 15
- Liver physiology and pathology 11
-
- Epigenetics and DNA Methylation 27
- Co-authors
- Osamu Yokosuka (83 shared papers)Atsushi Iwama (29 shared papers)Hiromitsu Saisho (18 shared papers)Hideki Taniguchi (7 shared papers)Hiromitsu Nakauchi (6 shared papers)Eiichiro Suzuki (63 shared papers)Sadahisa Ogasawara (70 shared papers)Yoshihiko Ooka (63 shared papers)
- Journals
- PLoS ONE (7 papers)Investigational New Drugs (6 papers)International Journal of Medical Sciences (5 papers)Hepatology International (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tetsuhiro Chiba
178 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Hepatology 1.5k
- Cancer Research 763
- Oncology 1.1k
- Molecular Biology 2.1k
- Epidemiology 924
Countries citing papers authored by Tetsuhiro Chiba
This map shows the geographic impact of Tetsuhiro Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhiro Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhiro Chiba more than expected).
Fields of papers citing papers by Tetsuhiro Chiba
This network shows the impact of papers produced by Tetsuhiro Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhiro Chiba. The network helps show where Tetsuhiro Chiba may publish in the future.
Co-authors
The 25 scholars most cited alongside Tetsuhiro Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties Hit paper breakdown → | 2006 | 529 |
| 2 | 2007 | 177 | |
| 3 | 2008 | 160 | |
| 4 | 2011 | 151 | |
| 5 | 2012 | 147 | |
| 6 | 1979 | 144 | |
| 7 | 2014 | 126 | |
| 8 | 1971 | 92 | |
| 9 | 2011 | 85 | |
| 10 | 2004 | 84 | |
| 11 | 2014 | 84 | |
| 12 | 2004 | 79 | |
| 13 | 1982 | 77 | |
| 14 | The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. | 1996 | 74 |
| 15 | 1987 | 72 | |
| 16 | 2014 | 69 | |
| 17 | 2013 | 65 | |
| 18 | 2015 | 65 | |
| 19 | 2000 | 63 | |
| 20 | 2009 | 63 |
About Tetsuhiro Chiba
Tetsuhiro Chiba is a scholar working on Hepatology, Molecular Biology, Epidemiology, Surgery and Oncology, having authored 190 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (53 papers), Liver Disease Diagnosis and Treatment (35 papers), Epigenetics and DNA Methylation (27 papers), Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (17 papers), Liver Disease and Transplantation (15 papers), Liver physiology and pathology (11 papers) and Cancer Mechanisms and Therapy (10 papers). The work is most often cited by research in Hepatology (1.5k citations), Cancer Research (763 citations), Oncology (1.1k citations), Molecular Biology (2.1k citations) and Epidemiology (924 citations). Tetsuhiro Chiba has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Osamu Yokosuka, Atsushi Iwama, Hiromitsu Saisho, Hideki Taniguchi, Hiromitsu Nakauchi, Eiichiro Suzuki, Sadahisa Ogasawara, Yoshihiko Ooka, Alvin W. Nienow and Fumio Imazeki. Their work appears in journals such as PLoS ONE, Investigational New Drugs, International Journal of Medical Sciences, Hepatology International and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.